Executive Director, Clinical QA

Who We Are:

At Neurocrine Biosciences, we pride ourselves on having a strong, inclusive, and positive culture based on our shared purpose and values. We know what it takes to be great, and we are as passionate about our people as we are about our purpose - to relieve suffering for people with great needs.

What We Do:

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis
* and uterine fibroids,
* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science.

For more information, visit , and follow the company on Linked In, X and Facebook. (
* in collaboration with Abb Vie)

About the Role:

Provides vision, strategic planning and management for departmental initiatives. Responsible for developing and setting strategy and operating plans for Clinical QA, and establishing compliance, procedures, and quality leadership. Responsible head for the Clinical QA matters for building and leading a team of highly trained and skilled quality professionals in order to implement the quality systems and perform activities necessary to ensure compliance and to ensure QA support of clinical study teams.

Prepares and leads the company through pre-approval inspections and clinical audits. Coordinates interdepartmental activities both internally and externally with regulatory, clinical, drug safety, and medical affairs to ensure clinical activities and internal functions meet quality standards and reflect risk-based principals. Ensures budget, schedules, and department performance requirements are met. Additionally, mentors and coaches all employees within the QA group and provide leadership and management within the entire team.

_

Your Contributions (include, but are not limited to):

Your Contributions (include, but are not limited to):

* Drives the strategic vision and direction for Clinical QA group

* Develops, executives, evaluates and adjusts strategy for Clinical QA and establishes strong, effective working relationships with internal and external stakeholders to achieve GCP compliance and Quality objectives

* Leads effort in developing, implementing and communicating of the GCP QA vision, goals, core capabilities, and values while championing a strong Quality Culture

* Partners with Clinical Development, Clinical Operations, Biostatistics, Pharmacovigilance, and Regulatory Affairs stakeholders regarding compliance issues and provides quality guidance and expert interpretation of GCP regulatory requirements and expectations

* Responsible for preparations and direct participation in regulatory inspections, which may include reviewing inspection readiness planning, mock inspections, performance of pre-approval inspections, and risk-based management of program inspection quality events

* Leads and project manages the development, implementation, and enhancements to the clinical QMS

* Participates in the evaluation, selection, compliance audit strategy, and oversight of global clinical investigators, contract clinical laboratories, and CROs

* Monitors the regulatory status of principal investigators and intervenes when sub-optimal performance is identified. Assists in remediation and corrective action plans to ensure all parts of the study are conducted properly

* Supports investigational new drug applications, ex-US clinical trial applications (CTA), and related correspondence from global regulatory authorities

* Develops metrics…